These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 298337

  • 21. Effect of acute volume alterations on norepinephrine and dopamine-beta-hydroxylase in normotensive and hypertensive subjects.
    Lake CR, Ziegler MG.
    Circulation; 1978 Apr; 57(4):774-8. PubMed ID: 630687
    [Abstract] [Full Text] [Related]

  • 22. Serum dopamine-beta-hydroxylase in psychiatric patients and normals. Effect of d-amphetamine and haloperidol.
    Markianos ES, Nyström I, Reichel H, Matussek N.
    Psychopharmacology (Berl); 1976 Nov 24; 50(3):259-67. PubMed ID: 826971
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Lithium: effects of short-term and chronic treatments in rats on the activity of dopamine-beta-hydroxylase (DBH) in the central versus peripheral nervous system.
    Banerji TK.
    Brain Res; 1982 Dec 16; 253(1-2):344-8. PubMed ID: 6295557
    [Abstract] [Full Text] [Related]

  • 25. Actions of amphetamine and antagonists on pupil diameter in the chronic sympathectomized dog.
    Sharpe LG, Pickworth WB, Martin WR.
    Psychopharmacology (Berl); 1977 Jul 18; 53(2):115-20. PubMed ID: 408837
    [Abstract] [Full Text] [Related]

  • 26. Circulating catecholamines and sympathetic activity after head injury.
    Clifton GL, Ziegler MG, Grossman RG.
    Neurosurgery; 1981 Jan 18; 8(1):10-4. PubMed ID: 7207763
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Involvement of central dopamine in the hyperthermia in rats produced by d-amphetamine.
    Ulus IH, Kiran BK, Ozkurt S.
    Pharmacology; 1975 Jan 18; 13(4):309-16. PubMed ID: 1187755
    [Abstract] [Full Text] [Related]

  • 29. Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning.
    Beninger RJ, Hahn BL.
    Science; 1983 Jun 17; 220(4603):1304-6. PubMed ID: 6857251
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pimozide attentuates d-amphetamine-induced sleep changes in man.
    Gillin JC, van Kammen DP, Bunney WE.
    Life Sci; 1978 May 22; 22(20):1805-10. PubMed ID: 209274
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Hemofiltration and plasma dopamine beta-hydroxylase activity.
    Spohr U, Schneider HW, Streicher E, Schrack R, Ritz E.
    Nephron; 1980 May 22; 25(3):121-6. PubMed ID: 7360296
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The effect of pimozide on CSF norepinephrine in schizophrenia.
    Sternberg DE, van Kammen DP, Lake CR, Ballenger JC, Marder SR, Bunney WE.
    Am J Psychiatry; 1981 Aug 22; 138(8):1045-50. PubMed ID: 7258379
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Hyporesponsivity of chronic schizophrenic patients to dextroamphetamine.
    Kornetsky C.
    Arch Gen Psychiatry; 1976 Dec 22; 33(12):1425-8. PubMed ID: 793562
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.